Post-market Clinical Follow-up Study Plan for Disposable Endoscopic Linear Cutter Stapler
1 other identifier
observational
302
1 country
1
Brief Summary
This study conducted a Post-Market Clinical Follow-Up study (PMCF) to evaluate the safety and effectiveness of the disposable endoscopic linear cutter stapler produced by Changzhou Ankang Medical Instrument Co., Ltd., through a retrospective analysis of the clinical data, to evaluate the safety and effectiveness of soft tissue resection, transection and anastomosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 4, 2024
CompletedFirst Posted
Study publicly available on registry
November 6, 2024
CompletedStudy Start
First participant enrolled
November 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedNovember 6, 2024
November 1, 2024
4 months
November 4, 2024
November 4, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Anastomosis success rate
The condition of no reoperation in situ was defined as successful anastomosis as determined by surgical records and hospitalization medical records.
the investigation sites will be collected from January 2023 to September 2024.
Secondary Outcomes (5)
Operation time
The investigation sites will be collected from January 2023 to September 2024.
Amount of intraoperative blood loss
the investigation sites will be collected from January 2023 to September 2024.
Intraoperative conversion (caused by the stapler and/or cartridge)
the investigation sites will be collected from January 2023 to September 2024.
Length of hospitalization
the investigation sites will be collected from January 2023 to September 2024.
All-cause re-hospitalization rate (within 6 months)
From the date of surgery to six months after the surgery
Other Outcomes (3)
Adverse events
From the date of surgery to six months after the surgery
Device deficiencies
From the date of surgery to six months after the surgery
Serious adverse events
From the date of surgery to six months after the surgery
Study Arms (1)
Disposable endoscopic linear cutter stapler
Interventions
Investigational devices of all the models of the staplers and its cartridge listed in Study Plan(Plan number: CAK-PMCF)
Eligibility Criteria
For patients who need to be operated for abdominal, gynecologic, pediatric, and thoracic, endoscopic (i.e., endo-therapy) surgery for the expeditious transection/resection of tissues and creation of anastomoses.
You may qualify if:
- Age unlimited and gender unlimited;
- The surgery type shall be endoscopic surgery;
- The departments of surgical procedures: general and thoracic surgical procedures;
- Investigational devices of all the models of the staplers and its cartridge listed in Section 2.3.
You may not qualify if:
- Patients undergoing surgery for contraindications to the product, such as severe mucosal edema, non-observation of hemostatic sites for surgery or off-label use, such as liver and spleen;
- Combined with other similar products (stapler) for resection, transection and anastomosis of the surgical site;
- Surgery record is incomplete, unable to extract main indicators related information.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Disposable endoscopic linear cutter stapler
Wujin District, Changzhou, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 4, 2024
First Posted
November 6, 2024
Study Start
November 15, 2024
Primary Completion
February 28, 2025
Study Completion
February 28, 2025
Last Updated
November 6, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share